M&A Deal Summary

Medtronic Acquires Smith & Nephew - Gynecology Business

On May 18, 2016, Medtronic acquired medical products company Smith & Nephew - Gynecology Business from Smith & Nephew for 350M USD

Acquisition Highlights
  • This is Medtronic’s 40th transaction in the Medical Products sector.
  • This is Medtronic’s 15th largest (disclosed) transaction.
  • This is Medtronic’s 2nd transaction in the United Kingdom.

M&A Deal Summary

Date 2016-05-18
Target Smith & Nephew - Gynecology Business
Sector Medical Products
Buyer(s) Medtronic
Sellers(s) Smith & Nephew
Deal Type Divestiture
Deal Value 350M USD

Target

Smith & Nephew - Gynecology Business

London, United Kingdom
Smith & Nephew - Gynecology Business is a medical technology platform used to remove abnormal uterine tissue such as polyps and fibroids.

Search 193,448 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Medtronic

Dublin, Ireland

website


Category Company
Founded 1949
Sector Medical Products
Employees95,000
Revenue 31.7B USD (2022)
DESCRIPTION
Medtronic's operational headquarters in Fridley, Minnesota.
Medtronic's operational headquarters in Fridley, Minnesota.

Medtronic is a global medical technology company whose products aim to alleviate pain, restore health, and extend life. Medtronic serves hospitals, physicians, clinicians, and patients in approximately 160 countries worldwide. Medtronic was founded in 1949 and is based in Dublin, Ireland with its operational headquarters in Fridley, Minnesota.


DEAL STATS #
Overall 45 of 59
Sector (Medical Products) 40 of 52
Type (Divestiture) 2 of 2
Country (United Kingdom) 2 of 3
Year (2016) 2 of 3
Size (of disclosed) 15 of 36
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-02-01 Bellco Società unipersonale a r.l

Mirandola, Italy

Bellco Società unipersonale a r.l is a provider of hemodialysis treatment solutions. Bellco offers therapies and systems for the treatment of renal failure, multiple organ failure and sepsis.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-06-27 HeartWare International

Framingham, Massachusetts, United States

HeartWare International, Inc. develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat patients around the world suffering from advanced heart failure. Dedicated to developing new, minimally invasive technologies to revolutionize the treatment of patients with end-stage heart failure, HeartWare has multiple technologies in development to offer progressively less-invasive mechanical circulatory support options. HeartWare's corporate headquarters are located in Framingham, Massachusetts, and the company has technology, operations, manufacturing and distribution centers in Miami Lakes, Florida; Arden Hills, Minnesota; and Hannover, Germany.

Buy $1.1B

Seller(S) 1

SELLER

Smith & Nephew

Watford, United Kingdom

website


Category Company
Founded 1856
Sector Medical Products
Employees18,000
Revenue 5.2B USD (2022)
DESCRIPTION

Smith & Nephew is a British-based multinational medical equipment manufacturing company. Smith & Nephew was founded in 1856 and is based in Watford, the United Kingdom.


DEAL STATS #
Overall 4 of 5
Sector (Medical Products) 1 of 1
Type (Divestiture) 4 of 5
Country (United Kingdom) 4 of 5
Year (2016) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-12 BST-CarGel

United States

BST-CarGel is a first-line cartilage repair product used along with microfracture and other bone marrow stimulation techniques for the initial treatment of most sizes of focal cartilage tears.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-10-23 Rotation Medical

Plymouth, Minnesota, United States

Rotation Medical, Inc. is a developer of a novel tissue regeneration technology for shoulder rotator cuff repair. The system incorporates a breakthrough technology and technique that balances biomechanics and biology to enhance the body’s natural healing response.

Buy $125M